The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will also serve on the board’s Audit and Finance Committees, further enhancing the board’s industry expertise and financial oversight capabilities. His addition is part of the board’s ongoing commitment and structured approach to refresh its membership in support of the company’s strategy, stakeholder needs, and the broader healthcare landscape.
July 28, 2025 — A wave of legal uncertainty has once again cast a shadow over Centene Corporation (NYSE:CNC), as shareholders grapple with the implications of a new class action lawsuit that alleges securities fraud and corporate misrepresentation. The development has sent ripples across the healthcare investment sector and raised
Centene Corporation (NYSE:CNC), a leading healthcare enterprise specializing in managed care services for government-sponsored health programs, has transformed itself over the past four decades from a small regional player into a national powerhouse. Headquartered in St. Louis, Missouri, Centene's rise has been defined by an aggressive acquisition strategy, targeted
Centene Corporation (NYSE:CNC), one of the largest managed healthcare providers in the United States, faced a severe market backlash this week as news of a federal securities fraud investigation rocked the company and its investors. Shares of Centene plunged sharply amid growing concerns over the scope and implications of
Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in 2012, Oscar Health has sought to simplify, personalize, and digitize the insurance experience, aiming to reshape a sector often
A groundbreaking clinical trial led by multidisciplinary researchers found that a digital asthma self-management (DASM) program significantly improved asthma symptom control in adults, with benefits sustained over 12 months. Program participants used everyday devices - like Apple Watch and iPhone – along with a tailored mobile app to help them manage their asthma. The findings represent some of the most compelling evidence to date supporting the use of digital health technologies in asthma care.
Hitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
